FDC Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
FDC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250 and 3.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
FDC Limited has submitted its financial results to NSE for the period ended March 31, 2025. The filing covers the company's reported earnings, income, and expense figures for the year/quarter ending March 31, 2025. The headline indicates a routine regulatory submission of audited or unaudited financial statements as required under listing rules. Detailed numbers such as revenue, profit after tax, and margins are not disclosed in the headline itself.
This is a standard compliance filing and does not by itself indicate any change in business fundamentals. Shareholders should review the detailed results document to assess actual financial performance and any forward-looking commentary.